uniQure: Pay

uniQure paid its 2 named executives $4.2M in total in FY2025 (Dec).

Pay of each named executive

Christian KlemtChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Walid Abi-SaabChief Medical Officer
FY2025 (Dec)
FY2024 (Dec)
2 years

CEO pay against the pay peers

In FY2024 (Dec), the median CEO pay of the 5 peers with pay on file was $6.8M. The CEO of uniQure was paid $3.1M, 55% below the median.

  1. 1Intellia Therapeutics
  2. 2MeiraGTx Holdings
  3. 3Agios Pharmaceuticals
  4. 4Denali Therapeutics
  5. 5Travere Therapeutics
  6. 6uniQure
  7. 7Alector, Inc.Not disclosed
  8. 8Editas MedicineNot disclosed
  9. 9Generation BioNot disclosed
  10. 10RegenxbioNot disclosed
  11. 11Revance TherapeuticsNot disclosed
  12. 12Rocket PharmaceuticalsNot disclosed
  13. 13Sage TherapeuticsNot disclosed
  14. 14Sangamo TherapeuticsNot disclosed
  15. 15Voyager TherapeuticsNot disclosed
  16. 16Wave Life ScienceNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.